Literature DB >> 616596

Factors influencing plasma carbamazepine concentrations.

C M Lander, M J Eadie, J H Tyrer.   

Abstract

Steady-state plasma carbamazepine levels were correlated with carbamazepine dose, expressed on a body weight basis, in 217 patients (some of whom were taking other anticonvulsants). Although there was a linear relation between plasma carbamazepine level and drug dose in the whole population studied, no such relation was found for patients taking carbamazepine alone. The factors responsible for this difference could not be identified in full, but interactions between carbamazepine and phenytoin were partly responsible.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 616596

Source DB:  PubMed          Journal:  Clin Exp Neurol        ISSN: 0196-6383


  5 in total

Review 1.  Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.

Authors:  E Spina; F Pisani; E Perucca
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

2.  The pharmacokinetics of carbamazepine.

Authors:  L M Cotter; M J Eadie; W D Hooper; C M Lander; G A Smith; J H Tyrer
Journal:  Eur J Clin Pharmacol       Date:  1977-12-28       Impact factor: 2.953

Review 3.  Antiepileptic drug toxicity: definition and mechanism of action.

Authors:  E Beghi; R Di Mascio
Journal:  Ital J Neurol Sci       Date:  1986-04

4.  Effect of dosage frequency of carbamazepine on drug serum levels in epileptic patients.

Authors:  K Ghose; D E Fry; J A Christfides
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Pharmacokinetics of nafimidone in patients with chronic intractable epilepsy.

Authors:  D M Treiman; S Gunawan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.